Society guideline links: Cryptococcosis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Opportunistic infections in individuals with HIV".)

International

●European Confederation of Medical Mycology (ECCM) and International Society for Human and Animal Mycology (ISHAM) in cooperation with American Society for Microbiology (ASM): Global guideline for the diagnosis and management of cryptococcosis (2024)

●World Health Organization (WHO): Guidelines for diagnosing, preventing, and managing cryptococcal disease among adults, adolescents, and children living with HIV (2022)

United States

●US Department of Health and Human Services (HHS): Federally approved clinical practice guidelines for HIV/AIDS

•Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Cryptococcosis (2024)

•Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV – Cryptococcosis (2013)

●American Academy of Pediatrics (AAP): Red Book – Cryptococcus neoformans and Cryptococcus gattii infections (cryptococcosis) (2024)

●European Confederation of Medical Mycology (ECCM) and International Society for Human and Animal Mycology (ISHAM) in cooperation with American Society for Microbiology (ASM): Global guideline for the diagnosis and management of cryptococcosis (2024)

●American Thoracic Society (ATS): Official statement on the treatment of fungal infections in adult pulmonary and critical care patients – Cryptococcosis (2011)

●Infectious Diseases Society of America (IDSA): Clinical practice guidelines for the management of cryptococcal disease, update (ARCHIVED; published 2010)

Europe

●European Confederation of Medical Mycology (ECCM) and International Society for Human and Animal Mycology (ISHAM) in cooperation with American Society for Microbiology (ASM): Global guideline for the diagnosis and management of cryptococcosis (2024)

●European Conference on Infections in Leukemia (ECIL): Recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients – Cryptococcus Ag (2012)

United Kingdom

●British Society for Medical Mycology (BSMM): Best practice recommendations for the diagnosis of serious fungal diseases (2015)

●British HIV Association (BHIVA) and British Infection Association (BIA): Guidelines for the treatment of opportunistic infection in HIV-seropositive individuals (2011)

Australia–New Zealand

●Royal Australasian College of Physicians (RACP): Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting (2021)